首页> 外文期刊>The Journal of Nuclear Medicine >Developmental Changes in P-Glycoprotein Function in the Blood-Brain Barrier of Nonhuman Primates: PET Study with R-^sup 11^C- Verapamil and ^sup 11^C-Oseltamivir
【24h】

Developmental Changes in P-Glycoprotein Function in the Blood-Brain Barrier of Nonhuman Primates: PET Study with R-^sup 11^C- Verapamil and ^sup 11^C-Oseltamivir

机译:非人类灵长类动物血脑屏障中P-糖蛋白功能的发育变化:R- ^ sup 11 ^ C-维拉帕米和^ sup 11 ^ C-Oseltamivir的PET研究

获取原文
获取原文并翻译 | 示例
           

摘要

P-glycoprotein (P-gp) plays a pivotal role in limiting the penetration of xenobiotic compounds into the brain at the blood-brain barrier (BBB), where its expression increases with maturation in rats. We investigated developmental changes in P-gp function in the BBB of nonhuman primates using PET with R-^sup 11^C-verapamil, a PET radiotracer useful for evaluating P-gp function. In addition, developmental changes in the brain penetration of ^sup 11^C-oseltamivir, a substrate for P-gp, was investigated as practical examples. Methods: PET studies in infant (age, 9 mo), adolescent (age, 24-27 mo), and adult (age, 5.6-6.6 y) rhesus monkeys [Macaca mulatta) were performed with R-^sup 11^C-verapamil and also with ^sup 11^C-oseltamivir. Arterial blood samples and PET images were obtained at frequent intervals up to 60 min after administration of the PET tracer. Dynamic imaging data were evaluated by integration plots using data collected within the first 2.5 min after tracer administration. Results: R-^sup 11^C-verapamil rapidly penetrated the brain, whereas the blood concentration of intact R-^sup 11^C-verapamil decreased rapidly in all subjects. The maximum brain uptake in infant (0.033% ± 0.007% dose/g of brain) and adolescent (0.020% ± 0.002% dose/g) monkeys was 4.1- and 2.5-fold greater, respectively, than uptake in adults (0.0082% ± 0.0007% dose/g). The clearance of brain R-^sup 11^C-verapamil uptake in adult monkeys was 0.056 ± 0.010 mL/min/g, significantly lower than that in infants (0.11 ± 0.04 mL/min/g) and adolescents (0.075 ± 0.023 mL/min/g). ^sup 11^C-oseltamivir showed little brain penetration in adult monkeys, with a clearance of R-^sup 11^C-verapamil uptake of 0.0072 and 0.0079 mL/min/g, slightiy lower than that in infant (0.0097 and 0.0104 mL/min/g) and adolescent (0.0097 and 0.0098 mL/min/g) monkeys. Conclusion: These results suggest that P-gp function In the BBB changes with development in rhesus monkeys, and this change may be closely related to the observed difference in drug responses in the brains of children and adult humans. [PUBLICATION ABSTRACT] Show less
机译:P-糖蛋白(P-gp)在限制异生物素化合物在血脑屏障(BBB)处进入大脑的过程中起着关键作用,在大鼠中,其表达随着成熟而增加。我们使用R- ^ sup 11 ^ C-维拉帕米(一种可用于评估P-gp功能的PET示踪剂),研究了非人类灵长类动物BBB中P-gp功能的发育变化。另外,作为实际例子,研究了Sup 11 C-奥司他韦(P-gp的底物)在脑渗透中的发育变化。方法:用R- ^ sup 11 ^ C-对恒河猴[Macaca mulatta]在婴儿(年龄9 mo),青少年(年龄24-27 mo)和成人(年龄5.6-6.6y)中进行PET研究。维拉帕米,也可联合使用^ sup 11 ^ C-oseltamivir。在施用PET示踪剂后的60分钟内,经常采集动脉血样本和PET图像。使用示踪剂给药后前2.5分钟内收集的数据通过积分图评估动态成像数据。结果:R- ^ sup 11 ^ C-维拉帕米迅速渗透到大脑中,而完整的R- ^ sup 11 ^ C-维拉帕米的血液浓度在所有受试者中均迅速下降。婴儿(0.033%±0.007%剂量/ g脑/ g)和青春期(0.020%±0.002%剂量/ g)猴的最大脑吸收分别比成人(0.0082%±)高4.1倍和2.5倍。 0.0007%剂量/ g)。成年猴脑R- ^ sup 11 ^ C-维拉帕米摄取的清除率为0.056±0.010 mL / min / g,明显低于婴儿(0.11±0.04 mL / min / g)和青少年(0.075±0.023 mL) / min / g)。 ^ sup 11 ^ C-奥司他韦在成年猴子中几乎没有脑渗透,R- ^ sup 11 ^ C-维拉帕米的摄取清除率为0.0072和0.0079 mL / min / g,比婴儿(0.0097和0.0104 mL)略低/ min / g)和青春期(0.0097和0.0098 mL / min / g)的猴子。结论:这些结果表明,BBB中P-gp功能随猕猴的发育而变化,并且这种变化可能与儿童和成人大脑中观察到的药物反应差异密切相关。 [出版物摘要]显示较少

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号